Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5085358
Max Phase: Preclinical
Molecular Formula: C48H91NNa2O14P2
Molecular Weight: 970.21
Molecule Type: Unknown
Associated Items:
ID: ALA5085358
Max Phase: Preclinical
Molecular Formula: C48H91NNa2O14P2
Molecular Weight: 970.21
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCC(=O)N[C@H]1[C@@H](OP(=O)([O-])[O-])O[C@H](COP(=O)(O)O)[C@@H](OC(=O)CCCCCCCCCCCCC)[C@@H]1OC(=O)CCCCCCCCCCCCC.[Na+].[Na+]
Standard InChI: InChI=1S/C48H93NO14P2.2Na/c1-4-7-10-13-16-19-22-25-28-31-34-37-42(50)49-45-47(62-44(52)39-36-33-30-27-24-21-18-15-12-9-6-3)46(41(40-59-64(53,54)55)60-48(45)63-65(56,57)58)61-43(51)38-35-32-29-26-23-20-17-14-11-8-5-2;;/h41,45-48H,4-40H2,1-3H3,(H,49,50)(H2,53,54,55)(H2,56,57,58);;/q;2*+1/p-2/t41-,45-,46-,47-,48-;;/m1../s1
Standard InChI Key: ZSPDLKXPXPYKEY-ILJGVBHZSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 970.21 | Molecular Weight (Monoisotopic): 969.6071 | AlogP: 12.34 | #Rotatable Bonds: 44 |
Polar Surface Area: 224.45 | Molecular Species: ACID | HBA: 10 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.90 | CX Basic pKa: | CX LogP: 14.19 | CX LogD: 7.11 |
Aromatic Rings: 0 | Heavy Atoms: 65 | QED Weighted: 0.02 | Np Likeness Score: 0.47 |
1. Facchini FA, Minotti A, Luraghi A, Romerio A, Gotri N, Matamoros-Recio A, Iannucci A, Palmer C, Wang G, Ingram R, Martin-Santamaria S, Pirianov G, De Andrea M, Valvano MA, Peri F.. (2021) Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo Activity., 64 (16.0): [PMID:34382796] [10.1021/acs.jmedchem.1c00896] |
Source(1):